Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07804095

AI-Supported Care Engagement for Next-step Delivery - Medicare Advantage

Conditions: Population Health Management, Patient Navigation

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 9906
Sponsor: Intermountain Health Care, Inc.

Location: Intermountain Health - ASCEND-MA Statewide Cohort Murray Utah

Summary

ASCEND-MA is an embedded, health-services study of at-risk Medicare Advantage members attributed to Intermountain Health in Utah. Participants are quasi-randomized based on their medical-record-number parity to either AI-supported, nurse-reviewed proactive care navigation or usual care. The study will evaluate whether the program changes cumulative payor-paid healthcare spending over 12 months.

Eligibility Criteria

Inclusion Criteria: •.Enrolled in an eligible Medicare Advantage plan and attributed to Intermountain Health in Utah. * Continuous Medicare Advantage enrollment for at least 6 months before the index date. * PRM Rising-Risk score (an internally derived prediction model) of at least 0.70 and Current-Risk score below 0.95 at index * Predicted year-over-year cost increase of at least 30%. * At least one targeted chronic condition: diabetes mellitus, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, hypertension, or hyperlipidemia. Exclusion Criteria: * Hospice enrollment at index. * End-stage renal disease requiring chronic dialysis at index. * Active oncology treatment at index. * Long-term institutional residence, including skilled-nursing-facility residence, at index. * Primary language cannot be supported through patient-directed outreach and no feasible alternative care-team communication pathway is available.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07804095). StuddyBuddy aggregates publicly available trial information.